Literature DB >> 8909239

Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples: identification and enumeration.

A Orfao1, L Escribano, J Villarrubia, J L Velasco, C Cerveró, J Ciudad, J L Navarro, J F San Miguel.   

Abstract

In the present paper we have used a three-color immunofluorescence procedure combined with flow cytometry cell analysis and sorting for the identification and enumeration of human mast cells in both normal and pathological bone marrow samples. Our results show that bone marrow mast cells are clearly identifiable on the basis of their light-scatter properties and strong CD117 expression. These cells were negative for the CD34, CD38, and BB4 antigens. In addition, they were CD33+ and displayed a high reactivity for the anti-IgE monoclonal antibody. The identity of the CD117-strong+ cells (mast cells) was confirmed by both microscopic examination and flow cytometry analysis. The overall frequency of mast cells in the bone marrow samples analyzed in the present study was constantly lower than 1%. The lowest frequencies corresponded to normal human bone marrow samples (0.0080 +/- 0.0082%) and the highest to those patients suffering from indolent systemic mast cell disease (0.40 +/- 0.13%). In summary, our results show that the identification and enumeration of bone marrow mast cells can be achieved using multiparametric flow cytometry. Moreover, once identified, mast cells are suitable for being characterized from the phenotypic and the functional point of view, facilitating the comparison between normal and abnormal mast cells.

Entities:  

Mesh:

Year:  1996        PMID: 8909239      PMCID: PMC1865253     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  41 in total

1.  The phenotype of human eosinophils, basophils, and mast cells.

Authors:  P Valent
Journal:  J Allergy Clin Immunol       Date:  1994-12       Impact factor: 10.793

2.  Report on the Fifth International Workshop on Human Leukocyte Differentiation Antigens, Boston, November 3-7, 1993.

Authors:  F Lanza; S Moretti; S Papa; F Malavasi; G Castoldi
Journal:  Haematologica       Date:  1994 Jul-Aug       Impact factor: 9.941

3.  Detection of rare cells at a frequency of one per million by flow cytometry.

Authors:  H J Gross; B Verwer; D Houck; D Recktenwald
Journal:  Cytometry       Date:  1993

4.  Distribution of mast cells and the effect of their mediators on contractility in human myometrium.

Authors:  M I Rudolph; K Reinicke; M A Cruz; V Gallardo; C Gonzalez; L Bardisa
Journal:  Br J Obstet Gynaecol       Date:  1993-12

5.  Mast cell numbers in melanocytic naevi and cutaneous neurofibromas.

Authors:  N J Carr; A Y Warren
Journal:  J Clin Pathol       Date:  1993-01       Impact factor: 3.411

6.  Flow cytometric evaluation of human basophils.

Authors:  P Gane; C Pecquet; P Lambin; N Abuaf; F Leynadier; P Rouger
Journal:  Cytometry       Date:  1993

7.  Mast cells in breast cancer.

Authors:  S Aaltomaa; P Lipponen; S Papinaho; V M Kosma
Journal:  Anticancer Res       Date:  1993 May-Jun       Impact factor: 2.480

8.  Origin of human mast cells: development from transplanted hematopoietic stem cells after allogeneic bone marrow transplantation.

Authors:  M Födinger; G Fritsch; K Winkler; W Emminger; G Mitterbauer; H Gadner; P Valent; C Mannhalter
Journal:  Blood       Date:  1994-11-01       Impact factor: 22.113

9.  Acute lymphoblastic leukemia (ALL): detection of minimal residual disease (MRD) at flow cytometry.

Authors:  A Orfao; J Ciudad; M C Lopez-Berges; A Lopez; B Vidriales; M D Caballero; B Valverde; M Gonzalez; J F San Miguel
Journal:  Leuk Lymphoma       Date:  1994

10.  The human cardiac mast cell: localization, isolation, phenotype, and functional characterization.

Authors:  W R Sperr; H C Bankl; G Mundigler; G Klappacher; K Grossschmidt; H Agis; P Simon; P Laufer; M Imhof; T Radaszkiewicz; D Glogar; K Lechner; P Valent
Journal:  Blood       Date:  1994-12-01       Impact factor: 22.113

View more
  10 in total

1.  Complete response to gemtuzumab ozogamicin in a patient with refractory mast cell leukemia.

Authors:  I Alvarez-Twose; P Martínez-Barranco; J Gotlib; A García-Montero; J M Morgado; M Jara-Acevedo; J D Merker; F J Peñalver; A Matito; Y Hou; L Sánchez-Muñoz; A Mayado; M Mollejo; L Escribano; A Orfao
Journal:  Leukemia       Date:  2016-02-15       Impact factor: 11.528

Review 2.  Urticaria pigmentosa and mastocytosis: the role of immunophenotyping in diagnosis and determining response to treatment.

Authors:  Cem Akin; Peter Valent; Luis Escribano
Journal:  Curr Allergy Asthma Rep       Date:  2006-07       Impact factor: 4.806

Review 3.  Anaphylaxis as a clinical manifestation of clonal mast cell disorders.

Authors:  A Matito; I Alvarez-Twose; J M Morgado; L Sánchez-Muñoz; A Orfao; L Escribano
Journal:  Curr Allergy Asthma Rep       Date:  2014-08       Impact factor: 4.806

4.  Second gene for gonadotropin-releasing hormone in humans.

Authors:  R B White; J A Eisen; T L Kasten; R D Fernald
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

5.  Expression of CD117 (c-Kit) on Circulating B Cells in Pediatric Schistosomiasis.

Authors:  Isaac O Onkanga; Rachael Hamilton; Pauline N M Mwinzi; Thomas Schneider; Bartholomew N Ondigo; Huldah Sang; Edna Ondari; Fredrick Rawago; Walter Jaoko; Maurice R Odiere; Lisa Ganley-Leal
Journal:  Infect Immun       Date:  2022-07-06       Impact factor: 3.609

6.  [Mastocytosis and eosinophilic leukemia: diagnostics and classification].

Authors:  K Sotlar; P Valent; H-P Horny
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

7.  Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcome.

Authors:  Almudena Matito; José Mario Morgado; Iván Álvarez-Twose; Laura Sánchez-Muñoz; Carlos Eduardo Pedreira; María Jara-Acevedo; Cristina Teodosio; Paula Sánchez-López; Elisa Fernández-Núñez; Ricardo Moreno-Borque; Andrés García-Montero; Alberto Orfao; Luis Escribano
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

Review 8.  Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes.

Authors:  David González-de-Olano; Almudena Matito; Alberto Orfao; Luis Escribano
Journal:  F1000Res       Date:  2016-11-14

9.  The spleen microenvironment influences disease transformation in a mouse model of KITD816V-dependent myeloproliferative neoplasm.

Authors:  Natalie Pelusi; Maike Kosanke; Tamara Riedt; Corinna Rösseler; Kristin Seré; Jin Li; Ines Gütgemann; Martin Zenke; Viktor Janzen; Hubert Schorle
Journal:  Sci Rep       Date:  2017-01-27       Impact factor: 4.379

10.  Development of Human Mast Cells from Hematopoietic Stem Cells within a 3D Collagen Matrix: Effect of Stem Cell Media on Mast Cell Generation.

Authors:  Tahereh Derakhshan; Rudra Bhowmick; Jerry W Ritchey; Heather Gappa-Fahlenkamp
Journal:  Stem Cells Int       Date:  2018-07-11       Impact factor: 5.443

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.